Nascent Biotech Inc (NBIO)
0.0899
+0.01
(+8.57%)
USD |
OTCM |
Jun 21, 16:00
Nascent Biotech Total Assets (Quarterly): 0.6413M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.6413M |
| September 30, 2023 | 1.043M |
| June 30, 2023 | 0.0789M |
| March 31, 2023 | 0.255M |
| December 31, 2022 | 0.5658M |
| September 30, 2022 | 1.201M |
| June 30, 2022 | 0.1833M |
| March 31, 2022 | 0.1054M |
| December 31, 2021 | 0.7517M |
| September 30, 2021 | 0.1054M |
| June 30, 2021 | 0.2759M |
| March 31, 2021 | 0.7514M |
| December 31, 2020 | 0.073M |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0992M |
| June 30, 2020 | 0.0004M |
| March 31, 2020 | 0.0032M |
| December 31, 2019 | 0.0018M |
| September 30, 2019 | 0.0055M |
| June 30, 2019 | 0.0054M |
| March 31, 2019 | 0.1315M |
| December 31, 2018 | 0.1033M |
| September 30, 2018 | 0.1102M |
| June 30, 2018 | 0.0491M |
| March 31, 2018 | 0.117M |
| December 31, 2017 | 0.8038M |
| March 31, 2017 | 0.8998M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.0004M
Minimum
Jun 2020
1.201M
Maximum
Sep 2022
0.3235M
Average
0.1054M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 5.357M |
| Palatin Technologies Inc | 11.41M |
| iBio Inc | 50.15M |
| Theriva Biologics Inc | 48.73M |
| Oragenics Inc | 3.534M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.6109M |
| Shareholders Equity (Quarterly) | 0.0304M |